1-(3-氨基丙基)-2-(乙氧基甲基)-1H-咪唑并[4,5-c]喹啉-4-胺合成路线 (共 9 条)
反应条件
1: With hydrogenchloride in methanol; water
T=50°C; 1 h;
2: With ammonia in water
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
Location in patent: Page/Page column 82-83 ;
反应条件
1: N,N-dimethyl-formamide; thionyl chloride / dichloromethane / 2.5 h / Reflux
2: triethylamine / dichloromethane / 0 °C
3: sodium tetrahydroborate / NiII chloride hexahydrate / methanol / 5 - 23 °C
4: hydrogenchloride; benzotriazol-1-ol / 1-methyl-pyrrolidin-2-one / 4 h / 120 °C / Inert atmosphere
5: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
6: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
7: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: nitric acid / propionic acid / 3.67 h / Reflux
2: N,N-dimethyl-formamide; thionyl chloride / dichloromethane / 2.5 h / Reflux
3: triethylamine / dichloromethane / 0 °C
4: sodium tetrahydroborate / NiII chloride hexahydrate / methanol / 5 - 23 °C
5: hydrogenchloride; benzotriazol-1-ol / 1-methyl-pyrrolidin-2-one / 4 h / 120 °C / Inert atmosphere
6: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
7: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
8: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: triethylamine / dichloromethane / 0 °C
2: sodium tetrahydroborate / NiII chloride hexahydrate / methanol / 5 - 23 °C
3: hydrogenchloride; benzotriazol-1-ol / 1-methyl-pyrrolidin-2-one / 4 h / 120 °C / Inert atmosphere
4: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
5: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
6: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: sodium tetrahydroborate / NiII chloride hexahydrate / methanol / 5 - 23 °C
2: hydrogenchloride; benzotriazol-1-ol / 1-methyl-pyrrolidin-2-one / 4 h / 120 °C / Inert atmosphere
3: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
4: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
5: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
2: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: hydrogenchloride; benzotriazol-1-ol / 1-methyl-pyrrolidin-2-one / 4 h / 120 °C / Inert atmosphere
2: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
3: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
4: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1: 3-chloro-benzenecarboperoxoic acid / dichloromethane / 5 - 20 °C
2: ammonium hydroxide; p-toluenesulfonyl chloride / dichloromethane / 0 - 20 °C
3: hydrogenchloride / water; methanol / 1 h / 50 °C
View Scheme
参考文献
Dainippon Sumitomo Pharma Co. Ltd.; AstraZeneca AB
Patent: US2011/136801 A1, 2011 ;
反应条件
1.1: 3-chloro-benzenecarboperoxoic acid / chloroform / |Reflux
2.1: hydrazine hydrate / ethanol / 90 °C
2.2: 2 h / 20 - 90 °C
View Scheme
参考文献
Cayla; Vernejoul, Fabienne; Debin, Arnaud; Drocourt, Daniel; Perouzel, Eric; Tiraby, Gérard; Lioux, Thierry
Patent: EP2674170 A1, 2013 ;